Search for: "Teva Pharmaceuticals"
Results 1201 - 1220
of 1,430
Sorted by Relevance
|
Sort by Date
24 Mar 2011, 12:53 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical Association Title: Stovall v. [read post]
5 Apr 2011, 2:35 pm
Par opposed the Motion to Dismiss arguing that pursuant to the Federal Circuit’s decision in Teva Pharmaceuticals USA, Inc. v. [read post]
31 Dec 2011, 1:00 pm
C-4329; and Teva Pharmaceuticals, Inc. and Cephalon, Dkt. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent Office… [read post]
24 Sep 2010, 1:15 pm
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson … [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs) Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi… [read post]
7 Jan 2018, 12:47 pm
Mepha, a Swiss subsidiary of Teva, sought a declaration of invalidity of Gilead’s Swiss SPC. [read post]
1 Feb 2013, 9:42 am
Wyeth Pharmaceuticals, Inc. [read post]
17 Mar 2020, 1:32 pm
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
23 Aug 2012, 12:47 pm
Teva Pharmaceuticals USA, Inc., 2010 WL 8357563, slip op. at 1-2 (Tex. [read post]
28 Apr 2019, 7:45 am
In Janssen v Teva (2009) the Federal Circuit stated that mere plausibility does not suffice to meet this requirement, if it did then patents could be obtained for little more than “respectable guesses”. [read post]
5 Mar 2018, 4:25 pm
Defendants in those cases include Johnson & Johnson, Janssen Pharmaceuticals, Teva Pharmaceuticals and Purdue Pharma, as well as several wholesale medication distributors. [read post]
5 Mar 2018, 4:25 pm
Defendants in those cases include Johnson & Johnson, Janssen Pharmaceuticals, Teva Pharmaceuticals and Purdue Pharma, as well as several wholesale medication distributors. [read post]
9 Nov 2010, 9:49 pm
This question was answered by the Hague Court of Appeal on 2 November 2010 in GlaxoSmithKline v Pharmachemie (a member of the Teva group). [read post]
30 May 2019, 6:02 am
Purdue Pharma and Teva, two of the nation’s largest supplier of opioids, have already reached multi-million dollar settlements with the state. [read post]
16 Mar 2011, 3:50 am
(EFF) US: Inter-agency group takes on counterfeit pharmaceuticals (PatentlyBIOtech) US: Recent Hatch-Waxman scholarship suggests patent settlement and product hopping create a ‘lethal combination’; another article proposes a ‘Smith Barney approach’ to 180-day exclusivity (FDA Law Blog) US: Sen Harkin urges FDA to avoid delays of generic drug approvals (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda files patent infringement complaint against Apotex… [read post]
21 Oct 2014, 9:03 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
